ASX today provided FY27 total expense growth and updated capital expenditure (capex) guidance for FY27 and FY28.

FY26 total expense growth and capex guidance are unchanged.

ASX forecasts FY27 total expenses growth of between 18% and 21%, with operating expense growth, excluding depreciation and amortisation, of between 13% and 16% compared to FY26 total expenses.

This is primarily driven by technology modernisation, the expanded Accelerate Program as part of ASX’s response to the ASIC Inquiry and investments to support customer-driven growth.

The Exchange increased FY27 capex guidance to between $180 million and $200 million (compared to previous guidance of between $160 million and $180 million) primarily driven by technology cost inflation and new product development, and forecast FY28 capex of between $170 million and $190 million.

Dividend policy remains unchanged, with payout ratio range of between 75% and 85% of underlying net profit after tax (NPAT). ASX expects to determine a payout at the bottom end of the range for at least the next two dividends.

ASX has entered into an agreement to sell its 49% interest in Sympli to ASX’s joint venture partner, ATI Group, for a nominal amount. This will result in an after-tax loss of approximately $12 million being recognised as a significant item in FY26.

On completion, ASX will no longer recognise its share of the operating losses of Sympli which were $4.4m after tax in 1H26 (equivalent to 1.7% of underlying NPAT for 1H26).

As previously communicated, a CHESS Replacement Partnership Program payment of $21 million (pre-tax) will be recognised as a significant item in FY26.

ASX is set to release its FY26 results on Thursday 13 August 2026.